News

Aspera Biomedicines Successfully Launches Second ADAR1p150 Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34

SAN DIEGO–(BUSINESS WIRE)–Aspera Biomedicines launches second ADAR1p150 crystallization experiment to the ISS aboard SpaceX CRS-34, advancing oral Rebecsinib for 20+ cancers. Click here to view original post Click Here to Publish/Feature Your Company or Product […]


ADVERTISEMENT — Advertise With Biotech Networks
News

AeroRx Therapeutics Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD

LA JOLLA, Calif.–(BUSINESS WIRE)– #Biotech–AeroRx Presents Positive Phase 2a Data for Inhaled AERO-007, the First Potential Nebulized LABA+LAMA Fixed-Dose Combination in Development for COPD Click here to view original post Click Here to Publish/Feature Your […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Design Therapeutics to Host Investor Webcast to Review Data from RESTORE-FA Trial of DT-216P2 for Friedreich’s Ataxia on Monday, May 18, 2026

CARLSBAD, Calif., May 17, 2026 (GLOBE NEWSWIRE) — Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, will announce data from the ongoing Phase 1/2 RESTORE-FA trial evaluating […]

News

Gossamer Bio to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 18, 2026

SAN DIEGO–(BUSINESS WIRE)—- $GOSS–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update

SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — First Tracks Biotherapeutics, Inc. (Nasdaq: TRAX), a clinical-stage biotechnology company advancing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases, today reported financial results […]

No Picture
News

Calidi Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Operational Highlights

SAN DIEGO, May 14, 2026 (GLOBE NEWSWIRE) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today reported its first quarter 2026 operating […]

News

Atrium Therapeutics Reports First Quarter 2026 Financial Results

SAN DIEGO, May 14, 2026 /PRNewswire/ — Atrium Therapeutics, Inc. (Nasdaq: RNA) (“Atrium,” “Atrium Therapeutics” or the “Company”), a biopharmaceutical company advancing precision cardiology by developing RNA therapeutics targeted to the heart, today reported financial […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Inhibrx Reports First Quarter 2026 Financial Results

SAN DIEGO, May 14, 2026 /PRNewswire/ — Inhibrx Biosciences, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”) today reported financial results for the first quarter of 2026. The biopharmaceutical company has two programs in ongoing clinical […]


ADVERTISEMENT — Advertise With Biotech Networks
News

Tri-City Medical Center Unveils Redesigned Emergency Department, Powered by $5.2 Million Community Investment

Largest project in Tri-City Hospital Foundation history transforms emergency care for Oceanside, Vista, and Carlsbad residents OCEANSIDE, Calif., May 14, 2026 /PRNewswire/ — Tri-City Medical Center today officially opens the doors to its redesigned Emergency […]


ADVERTISEMENT — Advertise With Biotech Networks
No Picture
News

Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimer’s disease

CARLSBAD, Calif.–(BUSINESS WIRE)–Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared compelling topline results from the Phase 2 CELIA study evaluating diranersen (IONIS-MAPTRx/BIIB080), an investigational antisense oligonucleotide (ASO) therapy targeting tau, in […]

News

The Ocean You’ve Never Heard

What happens when a composer and oceanographer listen to the ocean together? An unconventional partnership at the University of California San Diego has led to new music inspired by sounds from the seafloor that humans […]

No Picture
News

Belite Bio to Host Webcast on May 20, 2026, to Discuss First Quarter 2026 Financial Results

SAN DIEGO, May 13, 2026 (GLOBE NEWSWIRE) — Belite Bio, Inc. (NASDAQ: BLTE), (“Belite Bio®” or the “Company”), a clinical-stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have […]


ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks
News

Apricorn Enhances Aegis Secure Key 3.0 with Performance, Capacity and Environmental Protection Advancements

Product submitted to NIST CMVP for FIPS 140-3 Level 3 validation POWAY, Calif. and SAN DIEGO, May 13, 2026 /PRNewswire/ — Apricorn, the leading global provider of quantum-resistant hardware-encrypted external storage solutions, today announced significant […]

No Picture
News

Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

Phase 2b study design to be discussed at BIO International Convention in San Diego as Can-Fite advances partnership negotiations with leading oncology companies Click here to view original post Click Here to Publish/Feature Your Company […]